Orion predicted strong growth for darolutamide, the prescription prostate-cancer medication it co-developed with Bayer.

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

Benign prostate hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland, which is generally the shape and size ...

A research team at the University of Würzburg has, for the first time, uncovered how E. coli bacteria sneak into the prostate ...

Probiotics and broccoli could help to slow the spread of prostate cancer, research suggests. Broccoli, turmeric, pomegranate, ...

In this analysis, researchers aimed to evaluate the clinicopathologic characteristics, metastatic patterns, and survival outcomes in patients with metastatic prostate cancer and low-volume primary ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...

The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...

An Alabama Senate committee unanimously approved a bill Wednesday morning that would require health insurance companies to ...

The novel MEK inhibitor atebimetinib in combination with modified gemcitabine/nab-paclitaxel led to a 12-month overall ...